Diabetic gastroparesis.
Maderazo
Eufronio G
EG
D001682:Biological Availability; D048909:Diabetes Complications / Q000188:drug therapy*; D004917:Erythromycin / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D018589:Gastroparesis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D018942:Macrolides / Q000493:pharmacokinetics / Q000627:therapeutic use; D011964:Receptors, Gastrointestinal Hormone / Q000819:agonists; D018013:Receptors, Neuropeptide / Q000819:agonists
D005765:Gastrointestinal Agents; D018942:Macrolides; D011964:Receptors, Gastrointestinal Hormone; D018013:Receptors, Neuropeptide; C050802:motilin receptor; D004917:Erythromycin